Home› India› Ministry of Chemicals and Fertilizers› In exercise of the powers, conferred by paragraph 5, 11 and ...
Date: 2016-01-22 Category: Extra Ordinary State: Union Government Country: India

In exercise of the powers, conferred by paragraph 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. No. 1394(E) dated the 30th May, 2013

Issued by Ministry of Chemicals and Fertilizers · Department of Pharmaceuticals

Research with AI Agent Chat with Document Generate Summary Translate Helpful Share Add to Project Create Task

Executive Summary & Key Takeaways

This document is an order issued by the National Pharmaceutical Pricing Authority (NPPA), under the Ministry of Chemicals and Fertilizers, Government of India. The order, identified as S.O. 217(E), and dated January 22, 2016, withdraws Gazette Notification S.O. No. 1892(E) dated July 13, 2015, with immediate effect. The withdrawn notification pertained to the retail price fixation of Clopidogrel Atorvastatin Aspirin Capsule Deplatt CV 20 Forte for 1 Capsule, manufactured by M/s Surein Pharmaceuticals Pvt. Ltd. and marketed by M/s Torrent Pharmaceuticals Ltd. This action is taken in exercise of powers conferred by paragraphs 5, 11, and 15 of the Drugs Prices Control Order, 2013, read with S.O. No. 1394(E) dated May 30, 2013. The order's file reference is PN158262016/F. No. 8262016/D.P.NPPA/Div.II and is issued by Anand Prakash, Dy. Director.

Key Entities Referenced

Drugs Prices Control Order, 2013: A legal instrument that empowers the National Pharmaceutical Pricing Authority (NPPA) to regulate drug prices. National Pharmaceutical Pricing Authority (NPPA): A government regulatory agency responsible for controlling and fixing the prices of pharmaceutical products in India. Ministry of Chemicals and Fertilizers: The Indian government ministry responsible for the formulation and implementation of policies related to the chemical and fertilizer industries and the pharmaceutical sector. Clopidogrel Atorvastatin Aspirin Capsule Deplatt CV 20 Forte: A specific pharmaceutical product, a capsule containing a combination of Clopidogrel, Atorvastatin, and Aspirin, with the brand name Deplatt CV 20 Forte. Ms Surein Pharmaceuticals Pvt. Ltd.: The manufacturer of the pharmaceutical product Clopidogrel Atorvastatin Aspirin Capsule Deplatt CV 20 Forte. Ms Torrent Pharmaceuticals Ltd: The company responsible for marketing the pharmaceutical product Clopidogrel Atorvastatin Aspirin Capsule Deplatt CV 20 Forte. New Delhi, Delhi: The location where the order was issued. Gazette Notification S.O. No. 1892E dated 13th July, 2015: An official government publication being withdrawn by this order, related to retail price fixation.
Official Source Record View Original Source →
See Full Document Text
jftLVªh laö Mhö ,yö&33004@99 REGD. NO. D. L.-33004/99 vlk/kj.k EXTRAORDINARY Hkkx II—[k.M 3—mi&[k.M (ii) PART II—Section 3—Sub-section (ii) izkf/dkj ls izdkf'kr PUBLISHED BY AUTHORITY la- 193] ubZ fnYyh] 'kqØokj] tuojh 22] 2016@ek?k 2] 1937 No. 193] NEW DELHI, FRIDAY, JANUARY 22, 2016/ MAGHA 2 , 1937 jjjjllllkkkk;;;;uuuu vvvvkkkkSSjjSSjj mmmmooooZjZjZjZjdddd eeee==aa=a=a kkkkyyyy;;;; ¼¼¼¼vvvvkkkkSS""SS""kkkk////kkkk ffffooooHHHHkkkkkkkkxxxx½½½½ ¼¼¼¼jjjjkkkk""""VVVVªªhhªªhh;;;; vvvvkkkkSS""SS""kkkk////kkkk eeeewwYYwwYY;;;; ffffuuuu////kkkkkkkkZjZjZjZj....kkkk iiiizkzkzkzkffff////kkkkddddjjjj....kkkk½½½½ vvvvkkkknnnnss''ss''kkkk ubZ fnYyh] 22 tuojh] 2016 ddddkkkk----vvvvkkkk---- 222211117777¼¼¼¼vvvv½½½½----&&&& jk"Vªh; vkS"k/k ewY; fu/kkjZ .k ikzf/kdj.k] Hkkjr ljdkj ds jlk;u vkSj mojZ d ea=ky; }kjk tkjh dk- vk- 1394¼v½ rkjh[k 30 ebZ] 2013 ds lkFk ifBr vkS"k/k ¼dher fu;a=.k½ vkns'k] 2013 ds iSjk 5] 11 vkSj 15 }kjk iznRr 'kfDr;ksa dk iz;ksx djrs gq,] vkSj Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky; ¼jk"Vªh; vkS"k/k ewY; fu/kkjZ .k ikzf/kdj.k½ ds vkns'k la- dk- vk- 1892¼v½ rkjh[k 13 tqykbZ] 2015 Hkkjr ds jkti=] vlk/kkj.k esa izdkf'kr DyksfiMksxjsy$ ,Vkjs okLVsfVu$,lfizu dSilwy ¼MsiykV lhoh 20 QksVZ½] 1 dSilwy] eSllZ L;wfju QkekZL;wfVdYl izkbosV fyfeVsM }kjk fuferZ vkSj elS lZ Vkjs sUV QkekLZ ;wfVdYl fyfeVsM }kjk foi.ku] ds [kqnjk ewY; fu/kkZj.k ls lEcfU/kr gS] rRdky izHkko ls okfil yh tkrh gSA [dka- la-@158@26@2016@fo@Qk- la0 8¼26½@2016@Mhih@,uihih,-&fMoh--II] vkuUn izdk'k] mi&funs'kd MINISTRY OF CHEMICALS AND FERTILIZERS (Deaprtment of Pharmaceuticals) (NATIONAL PHARMACEUTICAL PRICING AUTHORITY) ORDER New Delhi, the 22nd January, 2016 S.O. 217(E).— In exercise of the powers, conferred by paragraph 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. No. 1394(E) dated the 30th May, 2013 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA) hereby withdraw the Gazette Notifcation S.O. No. 1892(E) dated 13th July, 2015, relating to retail price fixation of Clopidogrel + Atorvastatin + Aspirin Capsule (Deplatt CV 20 Forte) for 1 Capsule, manufactured by M/s Surein Pharmaceuticals Pvt. Ltd. and Marketed by M/s Torrent Pharmaceuticals Ltd, with immediate effect. [PN/158/26/2016/F/F. No. 8(26)/2016/D.P./NPPA-Div.-II] ANAND PRAKASH, Dy. Director 345 GI/2016 Printed by the Manager, Government of India Press, Ring Road, Mayapuri, New Delhi-110064 and Published by the Controller of Publications, Delhi-110054.

Continue your research

Related Documents from Ministry of Chemicals and Fertilizers